Wolverine Stack: 2026 Research Guide (BPC-157 + TB-500)

The Wolverine Stack — also known as the Wolverine Blend or informally as the "wolverine peptide" — is one of the most extensively researched dual-peptide combinations in preclinical tissue-repair science. It combines BPC-157 (10mg) and TB-500 (10mg) co-lyophilized in a single vial, delivering 20mg of active peptide content per unit. This 2026 research guide covers the molecular attributes of both peptides, the origin of the name, the mechanism synergy between angiogenesis and actin-binding, research applications, the reconstitution protocol for a 20mg blend, storage, regulatory status, and where to buy the Wolverine Stack in Europe under the Research Use Only (RUO) framework.

What is the Wolverine Stack?

The Wolverine Stack is a co-lyophilized two-peptide research combination containing BPC-157 (Body Protection Compound-157) and TB-500 (a Thymosin Beta-4 active fragment) in a single vial. Because both peptides share the same vial, the same diluent volume, and the same reconstitution timestamp, the blend eliminates the cross-vial dilution variability that occurs when researchers reconstitute two separate vials and mix them manually. The stoichiometric ratio is fixed at 1:1 (10mg BPC-157 : 10mg TB-500).

The Wolverine Blend is the neutral commercial name that Pepspan uses for this product. "Wolverine Stack," "Wolverine Peptide," and "Wolverine 20mg" are all informal synonyms used across research forums, biohacker communities, and search queries. Some suppliers in the United States (notably the Mequon, Wisconsin research-peptide market) have used variants of the same nickname — hence queries like "wolverine blend mequon." The product itself is chemically identical across suppliers when both peptides are >98% pure.

Origin of the name — the X-Men Wolverine reference

The "Wolverine" nickname is not a scientific term. It is an informal researcher label derived from the X-Men comic character Wolverine, whose fictional mutant ability is rapid regeneration of damaged tissue — bones, muscle, skin. Because BPC-157 and TB-500 are the two most widely studied peptides in preclinical tissue-repair research, the community adopted the "Wolverine" nickname as shorthand for the two-peptide combination associated with recovery and tissue regeneration research.

The nickname has no scientific basis and does not describe a specific chemical entity — it describes the informal research use case. Pepspan explicitly frames the product under its neutral commercial name (Wolverine Blend) with the exact peptide content (BPC-157 10mg + TB-500 10mg) declared on the label and COA.

Molecular attributes — both peptides side by side

Mechanism synergy — angiogenesis + actin binding

The reason researchers combine BPC-157 and TB-500 in a single stack is that their mechanisms are complementary, not overlapping. Each peptide targets a distinct axis of the tissue-repair cascade:

BPC-157 — the vascular axis

BPC-157 has been extensively documented in preclinical literature (notably by the Sikirić group in Zagreb) to modulate the VEGF-receptor axis and promote angiogenesis — the formation of new blood vessels from existing vasculature. In tendon and ligament injury models, angiogenesis is a rate-limiting step in tissue perfusion and metabolic waste clearance. BPC-157 has also been described to interact with the nitric oxide pathway and to protect gastric mucosa (its original discovery context — hence "Body Protection Compound"). Its short 15-amino-acid sequence gives it exceptional stability, including partial resistance to gastric acid degradation.

TB-500 — the cytoskeletal axis

TB-500 is a synthetic active fragment of endogenous Thymosin Beta-4, one of the most abundant proteins in mammalian cells. Its primary molecular mechanism is G-actin sequestration — TB-500 binds free G-actin monomers, controlling their availability for polymerization into F-actin filaments. This regulation of actin polymerization dynamics influences cell migration, extracellular matrix organization, and wound closure. In preclinical dermal and musculoskeletal wound models, TB-500 accelerates the migration of endothelial cells, fibroblasts, and keratinocytes.

Why the combination is more than the sum of parts

Angiogenesis (BPC-157 axis) delivers new perfusion to the injury site; actin polymerization dynamics (TB-500 axis) enable the newly-perfused cells to migrate into the injured tissue and rebuild it. Preclinical comparative studies of single-peptide versus dual-peptide interventions frequently report additive or supra-additive effects on tissue-repair endpoints. This mechanism-level complementarity is why the Wolverine Stack has become the standard reference tool for dual-peptide recovery research.

Research applications

The Wolverine Stack is used across several preclinical research lines:

1. Tendon and ligament injury models

Preclinical rat and rabbit models of Achilles tendon transection, medial collateral ligament rupture, and rotator cuff injury frequently use the BPC-157 + TB-500 combination as a benchmark tissue-repair intervention. Endpoints typically include collagen fiber organization (histology), biomechanical tensile strength, and functional recovery scores.

2. Musculoskeletal recovery research

Muscle injury models — laceration, contusion, or eccentric-exercise-induced damage — use the blend to study the interaction between vascular delivery (BPC-157) and myoblast migration (TB-500) in muscle regeneration.

3. Dermal wound healing models

Full-thickness skin wound models, burn models, and diabetic wound-healing models use the combination to investigate the interaction between angiogenesis and keratinocyte/fibroblast migration.

4. Angiogenesis assays

Chick chorioallantoic membrane (CAM) assays, aortic ring assays, and Matrigel plug assays specifically isolate the vascular contribution — used to characterize the BPC-157 half of the blend.

5. Cell migration assays

Scratch wound assays, Boyden chamber assays, and transwell migration studies isolate the TB-500 contribution to cell motility.

Reconstitution protocol — 20mg co-lyophilized vial

The Wolverine Blend ships as a lyophilized off-white powder in a single 10ml amber sealed vial. The following is a standard laboratory reconstitution protocol — researchers should validate against their own internal SOPs.

1. Bring both vials to room temperature (20-25 °C) before opening. Cold vials cause moisture condensation on the powder.
2. Calculate diluent volume for target concentration:
   • 20 mg + 2 ml BAC = 10 mg/ml combined = 5 mg/ml of each peptide (highest concentration)
   • 20 mg + 4 ml BAC = 5 mg/ml combined = 2.5 mg/ml of each peptide (standard research concentration)
   • 20 mg + 5 ml BAC = 4 mg/ml combined = 2 mg/ml of each peptide (dilute)
3. Aseptic technique: disinfect both septums with 70% isopropanol. Use a sterile syringe (typically 3 ml, 27-30 gauge).
4. Inject bacteriostatic water (0.9% benzyl alcohol) slowly along the inner wall of the blend vial — never directly onto the powder bed.
5. Swirl gently for 30-60 seconds until fully dissolved. Do not shake — vigorous agitation can fragment the longer TB-500 chain (43 amino acids is meaningfully longer than BPC-157's 15).
6. Solution should be clear and colorless. Any cloudiness, particulates, or discoloration = discard.
7. Store immediately at 2-8 °C (refrigerator, not freezer). Use within 28 days.

Storage

• Lyophilized (unopened): 4 °C for several months; -20 °C for long-term stability (years).
• Reconstituted solution: 2-8 °C, use within 28 days.
• Never freeze reconstituted solution — freeze/thaw cycles degrade both peptides, especially TB-500.
• Protect from direct light. Amber vials help but reduce light exposure regardless.
• Avoid repeated temperature excursions — a stable refrigerator location is preferable to shelf-door storage.

Buy the Wolverine Stack at Pepspan

Pepspan sells the Wolverine Blend across the EU and EEA under the Research Use Only (RUO) framework. Every batch is tested independently by Janoshik Analytical (Brno, Czechia) for HPLC purity, mass-spectrometry identity confirmation, residual solvent screening, and microbial contamination testing. Certificates of Analysis (COA) are included with every order.

Pricing (2026):

• Wolverine Blend 20mg (BPC-157 10mg + TB-500 10mg): €89 per vial
• Wholesale (10+ units of the same SKU): 20% automatic discount = €71.20/vial
• Free shipping: orders over €100
• Ships to: all 27 EU member states + EEA from the European warehouse — no customs friction

Alternative: buy BPC-157 and TB-500 separately

If your protocol requires independent concentration curves per peptide, one-peptide controls, or asymmetric dosing ratios, buy the two peptides as separate vials:

• BPC-157 10mg lyophilized — €59
• TB-500 10mg lyophilized — €79
• Combined total: €138 (versus €89 for the co-lyophilized blend)

The individual-vial route costs meaningfully more but preserves protocol flexibility. For most standard tissue-repair research where a fixed 1:1 ratio is acceptable, the co-lyophilized Wolverine Blend is the more efficient choice.

Regulatory framework in Europe

The Wolverine Blend is sold legally across the EU and EEA as a laboratory reagent under Research Use Only (RUO). Neither the constituent peptides (BPC-157, TB-500) nor the blend are authorized as medicinal products by the EMA (European Medicines Agency) or by any national regulator (BfArM in Germany, ANSM in France, AEMPS in Spain, INFARMED in Portugal). They cannot be marketed, prescribed, or used for human or veterinary consumption.

By purchasing, the customer confirms:

• They are a qualified researcher, laboratory professional, or R&D personnel
• The product will be used exclusively for scientific research
• They understand and accept the Research Use Only (RUO) framework and Pepspan's disclaimers

Full legal framework: Research peptides legal status in Europe.

Product box — the Wolverine Stack ecosystem

Frequently Asked Questions

What is the Wolverine Stack?

A co-lyophilized 2-peptide research stack: BPC-157 (10mg) + TB-500 (10mg) in one vial, 20mg total. Also known as the Wolverine Blend or wolverine peptide. The most extensively studied dual-peptide combination in preclinical tissue-repair research.

Where does the name Wolverine Stack come from?

An informal researcher nickname derived from the X-Men comic character Wolverine (fictional rapid tissue healing). BPC-157 + TB-500 became the "Wolverine Stack" in research forums. The label has no scientific standing — it's colloquial shorthand for the tissue-repair peptide pair.

What makes the Wolverine Stack synergistic?

Complementary mechanisms: BPC-157 promotes angiogenesis (VEGF-receptor axis) — new vascular perfusion. TB-500 sequesters G-actin monomers — regulates cell migration and wound closure. Angiogenesis delivers perfusion, actin dynamics deliver cellular migration into the injury site.

How do I reconstitute the 20mg vial?

Room temperature → calculate diluent (20mg+2ml = 10mg/ml combined = 5mg/ml each; 20mg+4ml = 5mg/ml combined = 2.5mg/ml each) → inject bacteriostatic water along the vial wall (never on powder) → swirl gently (don't shake — protects longer TB-500 chain) → store 2-8 °C, use within 28 days.

Where can I buy the Wolverine Stack in Europe?

Pepspan sells the Wolverine Blend at €89/vial, EU stock, Janoshik COA per batch. Ships to all 27 EU/EEA countries with no customs. Wholesale 10+ vials = 20% automatic discount (€71.20/vial). No prescription — Research Use Only (RUO).

Wolverine Blend vs BPC-157 + TB-500 separately?

Blend (€89): fixed 1:1 ratio, one vial, one diluent — protocol consistency. Separate vials (€59 + €79 = €138): independent concentration curves, one-peptide controls, asymmetric dosing — maximum flexibility. Cost-wise the blend is meaningfully cheaper.

Is the Wolverine Stack legal in Europe?

Yes. Sold legally across EU/EEA as a laboratory reagent under Research Use Only (RUO). Not authorized as a medicinal product by the EMA or any national regulator. No prescription required for research purchase. Buyers must be qualified researchers.

How should I store the Wolverine Stack?

Lyophilized: 4 °C several months / -20 °C years. Reconstituted: 2-8 °C, use within 28 days. Never freeze the reconstituted solution — freeze/thaw degrades both peptides, particularly the longer TB-500 chain. Protect from direct light.

What research applications is the Wolverine Stack used for?

Tendon/ligament injury models, muscle repair models, dermal wound healing, angiogenesis assays (CAM, aortic ring), cell migration assays (scratch wound, Boyden chamber). Reference tool in comparative studies of single-peptide vs multi-peptide recovery interventions. Research Use Only.